UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018242
Receipt number R000020951
Scientific Title Safety and efficacy of Video-Assisted Thoracoscopic Surgery for Esophageal cancer
Date of disclosure of the study information 2015/07/09
Last modified on 2020/07/12 22:16:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of Video-Assisted Thoracoscopic Surgery for Esophageal cancer

Acronym

Safety and efficacy of Video-Assisted Thoracoscopic Surgery for Esophageal cancer

Scientific Title

Safety and efficacy of Video-Assisted Thoracoscopic Surgery for Esophageal cancer

Scientific Title:Acronym

Safety and efficacy of Video-Assisted Thoracoscopic Surgery for Esophageal cancer

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of Video-Assisted Thoracoscopic operation for patients with esophageal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The harmful case that occurred within 30 days after the operation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Video-Assisted Thoracoscopic operation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Histological diagnosis as the esophageal cancer
2. Esophageal lesion is in the thoracic esophagus (UICC-TNM 7th edition)
3. Single or multiple esophageal lesions
4. cT1-3, N0 (UICC 7th edition)
5. Aged over 20 years and under 80 years at the time of registration
6. Performance Status(ECOG):0 or 1
7. Previously not treated for esophageal cancer (Diagnosed as ycT1-3, N0 after the preoperative chemotherapy)
8. Previously not treated chemotherapy or radiotherapy for other cancers.
9. Previously not treated for the right side of body with the thoracotomy. (incl. thoracoscopic surgery)
10. Adequate organ function
11. Written IC

Key exclusion criteria

1. Tumor progress range: T4 (UICC 7th edition)
2. The central of lesion is at the esophago-gastric junction rather than the anal side.
3. Serious organ derangements
4. Serious active infections
5. Serious complications
6. Pregnant, lactating or women of child-bearing potential.
7. The patient is judged unsuitable for the subject of this study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Sohda

Organization

Gunma University Hospital

Division name

Integrative Center of General Surgery

Zip code


Address

3-39-15 Showa-machi Maebashi Gunma 371-8511

TEL

027-220-8224

Email

msohda@gunma-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Sohda

Organization

Gunma University Hospital

Division name

Integrative Center of General Surgery

Zip code


Address

3-39-15 Showa-machi Maebashi Gunma 371-8511

TEL

027-220-8224

Homepage URL


Email

msohda@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 10 Day

Date of IRB

2015 Year 05 Month 14 Day

Anticipated trial start date

2015 Year 07 Month 09 Day

Last follow-up date

2020 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 07 Month 08 Day

Last modified on

2020 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020951


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name